Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PALIVIZUMAB vs PANCRELIPASE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PALIVIZUMAB vs PANCRELIPASE: Safety Overview

Metric PALIVIZUMAB PANCRELIPASE
Total FAERS Reports 11,419 724
Deaths Reported 1,248 66
Death Rate 10.9% 9.1%
Hospitalizations 6,461 281
Average Patient Age 0.8 yrs 52.0 yrs
% Female Patients 42.2% 50.4%
Manufacturer Swedish Orphan Biovitrum AB (publ) N/A
Route INTRAMUSCULAR N/A
Marketing Status Prescription Discontinued